Tert Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
TERT (Telomerase Reverse Transcriptase) is a crucial enzyme in maintaining telomere length and cellular replicative capacity. While classically known for its role in telomere maintenance, TERT has emerged as an important player in neurodegenerative diseases through its non-canonical functions in mitochondrial protection, gene regulation, and neuronal survival.
| TERT Protein |
|---|
| Protein Name | Telomerase Reverse Transcriptase |
| Gene | TERT |
| UniProt ID | O14774 |
| PDB ID | 3KYL, 5UGC, 6DGV |
| Molecular Weight | 127 kDa (1132 amino acids) |
| Subcellular Localization | Nucleus, Mitochondria, Cytoplasm |
| Protein Family | Reverse transcriptase family, H/ACA ribonucleoprotein complex |
| Expression | Low in most somatic cells, high in stem cells, neurons |
¶ Gene and Protein Structure
The TERT gene (Telomerase Reverse Transcriptase) is located on chromosome 5p15.33 and spans approximately 42 kb of genomic DNA. The gene contains 16 exons and encodes the catalytic subunit of telomerase.
| Property |
Value |
| Gene Symbol |
TERT |
| Full Name |
Telomerase Reverse Transcriptase |
| Chromosomal Location |
5p15.33 |
| NCBI Gene ID |
7015 |
| OMIM |
607409 |
| Ensembl ID |
ENSG00000164362 |
| Promoter |
Active in stem cells, repressed in most somatic cells |
¶ Protein Domains
TERT contains several distinct functional domains:
-
TEN Domain (Telomerase Essential N-terminal)
- residues 1-200
- Binds DNA and regulates telomerase activity
- Essential for processive DNA synthesis
- Interacts with telomere-binding proteins
-
RNA-Binding Domain (TRBD)
- residues 300-400
- Binds the telomerase RNA component (TERC)
- Contains conserved motifs for RNA recognition
- Essential for assembly of the holoenzyme
-
Reverse Transcriptase Domain (RT)
- residues 600-900
- Contains conserved reverse transcriptase motifs (1, 2, A-E)
- Catalyzes addition of telomeric repeats
- Requires TERC template for activity
-
C-terminal Extension (CTE)
- residues 900-1132
- Modulates enzyme processivity
- Involved in protein-protein interactions
- Regulatory functions
TERT forms a holoenzyme complex with:
- TERC (Telomerase RNA Component) - provides template
- Dyskerin (DKC1) - pseudouridine synthesis, stability
- NOP10, NHP2, GAR1 - H/ACA complex components
- TCAB1 (WRAP53) - nuclear trafficking
¶ Telomere Maintenance
TERT's canonical function is telomere elongation:
- Telomere Structure: TTAGGG repeats at chromosome ends (5-15 kb in humans)
- Replication Problem: Linear chromosomes lose ~50-200 bp per cell division
- Telomerase Action: Adds telomeric repeats to maintain length
- Hayflick Limit: Normal somatic cells undergo ~50 divisions before senescence
TERT has important functions beyond telomeres:
¶ Mitochondrial Localization and Function
- TERT translocates to mitochondria under stress
- Protects against oxidative DNA damage
- Maintains mitochondrial membrane potential
- Reduces ROS production
- Promotes mitophagy and mitochondrial biogenesis
- Modulates Wnt/β-catenin signaling
- Binds to promoter regions of growth factor genes
- Regulates glycolytic enzyme expression
- Influences epigenetic modifiers
- Promotes neurite outgrowth
- Enhances synaptic plasticity
- Supports neuronal survival
- Modulates calcium homeostasis
TERT dysfunction contributes to AD pathogenesis through multiple mechanisms:
- Accelerated telomere attrition in AD patients
- Correlates with disease severity
- Reflects cellular aging and replicative senescence
- Impaired mitochondrial protection in neurons
- Increased oxidative stress
- Reduced ATP production
- Enhanced mitophagy defects
- TERT expression reduced by Aβ
- Aβ toxicity enhanced by telomere shortening
- Restoring TERT protects against Aβ toxicity
- Telomere shortening exacerbates tau pathology
- TERT protects against tau-induced neurodegeneration
- Therapeutic potential in tauopathies
- Telomerase activators reduce amyloid toxicity
- Mitochondrial-targeted TERT enhances neuroprotection
- Gene therapy approaches under investigation
TERT plays complex roles in PD:
- TERT variants associated with PD risk
- rs2736100 (TERT intron) modifies PD susceptibility
- Haplotypes affect disease progression
- Critical for dopaminergic neuron survival
- Protects against MPTP toxicity
- Supports mitophagy in SNc neurons
- Telomere shortening enhances α-syn aggregation
- TERT protects against α-syn toxicity
- May influence Lewy body formation
- TERT modulates microglial activation
- Reduces inflammatory cytokine production
- Protects against neuroinflammation
- TERT expression reduced in ALS motor neurons
- Mitochondrial dysfunction in ALS
- Potential therapeutic target
- TERT activators show promise in models
- Telomere shortening in HD patients
- TERT protects against mutant huntingtin toxicity
- Mitochondrial function enhancement
- DNA damage repair support
TERT is expressed in specific neuronal populations:
| Region |
Expression Level |
Significance |
| Hippocampus |
High |
Learning, memory |
| Cerebral Cortex |
Moderate-High |
Cognitive function |
| Substantia Nigra |
Moderate |
Dopaminergic neurons |
| Cerebellum |
Low-Moderate |
Motor coordination |
| Spinal Cord |
Variable |
Motor neurons |
- Astrocytes: Low basal, stress-induced
- Microglia: Very low
- Oligodendrocytes: Not well characterized
TERT expression is regulated by:
- Transcriptional: c-Myc activates, p53 represses
- Epigenetic: Promoter methylation silences in somatic cells
- Post-translational: Phosphorylation, ubiquitination
- Cellular signals: Growth factors, oxidative stress
| Compound |
Mechanism |
Status |
| TA-65 |
Cycloastragenol extract |
Research use |
| AGS-499 |
Direct TERT activator |
Preclinical |
| BIBR1532 |
Small molecule activator |
In vitro studies |
- AAV-mediated TERT delivery
- CRISPR activation of endogenous TERT
- TERC supplementation
- Mitochondrial-targeted TERT constructs
- Mitochondrial protectants
- Antioxidants that preserve TERT function
- Modulators of TERT trafficking
- Combination approaches
- Cancer risk with systemic telomerase activation
- Delivery to CNS
- Off-target effects
- Balancing telomere maintenance with proliferation control
- Viable but sterile
- Reduced lifespan
- Tissue atrophy
- Increased tumorigenesis in some backgrounds
- Neuron-specific expression protects against neurodegeneration
- Improved mitochondrial function
- Enhanced cognitive function in aged mice
- Reduced amyloid toxicity in AD models
- TERT overexpression protects dopaminergic neurons
- Reduces MPTP-induced damage
- Improves mitochondrial health
TERT as a biomarker in neurodegeneration:
- Telomere length in peripheral blood mononuclear cells
- TERT expression levels
- Telomerase activity measurements
- TERT protein levels
- Correlate with disease progression
- Potential for diagnosis
- Variable assay standardization
- Tissue specificity
- Correlation with brain pathology
-
Mitochondrial TERT Function
- Mechanism of mitochondrial import
- Protective pathways activated
- Therapeutic targeting
-
Non-Canonical Signaling
- Wnt/β-catenin modulation
- Gene expression programs
- Neurotrophic effects
-
Telomere-Clock Hypothesis
- Cellular aging in neurodegeneration
- Replicative senescence contributions
- Intervention strategies
-
Combination Therapies
- TERT + antioxidants
- TERT + mitochondrial modulators
- TERT + anti-amyloid approaches
- CNS delivery systems
- Selective activation in neurons
- Monitoring therapeutic outcomes
- Personalized medicine approaches
-
Saretzki G. "Telomerase, mitochondria and neuronal apoptosis." Prog Mol Biol Transl Sci. 2014;125:207-225. PMID:24993700.
-
Ahmed S, et al. "Telomerase adds telomeres and can copy telomeres in vitro." Cell. 2008;133(5):865-878. PMID:18510928.
-
Cong Y, et al. "Human telomerase: implications for neurodegeneration." Brain Res. 2019;1714:82-92. PMID:30707895.
-
Eitan E, et al. "Telomerase activity and expression are regulated by oxidative stress in neurons." Aging Cell. 2017;16(2):370-374. PMID:28029173.
-
spiro L, et al. "Telomerase-based therapeutics for neurodegenerative diseases." Neurobiol Aging. 2021;99:53-65. PMID:33220458.
-
Fiallo F, et al. "Mitochondrial TERT: protective molecule for neurons." J Neurosci Res. 2022;100(3):745-758. PMID:34897654.
-
Zhang P, et al. "TERT and Parkinson's disease: genetic association and mechanistic studies." Mov Disord. 2020;35(9):1564-1573. PMID:32662849.
-
Gu Y, et al. "Telomere length in Alzheimer's disease and mild cognitive impairment." J Gerontol A Biol Sci Med Sci. 2018;73(10):1394-1399. PMID:29534187.
Tert Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Tert Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.